Medicare Enrolled
Dr. Wissam Derian, MD
Cardiovascular Disease · Quincy, IL
Practice pattern: Remote & Cardiac
— Practice combining remote and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Derian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Derian?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Derian
Dr. Wissam Derian is a cardiovascular disease specialist in Quincy, IL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Derian performed 8,185 Medicare services across 5,744 unique beneficiaries.
Between the years covered by Open Payments, Dr. Derian received a total of $13,440 from 39 pharmaceutical and/or device companies across 936 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Derian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 4% volume in IL
$13,440 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,185
Medicare services
Top 4% in IL for cardiovascular disease
5,744
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~455 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
972 | $59 | $195 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
612 | $130 | $851 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
600 | $44 | $122 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
593 | $10 | $84 |
| Outpatient cardiac rehabilitation with ECG monitoring Supervised heart rehabilitation program including electrocardiogram monitoring and professional healthcare services. |
503 | $18 | $93 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
469 | $14 | $103 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
428 | $20 | $126 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
378 | $95 | $136 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
343 | $89 | $288 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
288 | $60 | $233 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
275 | $101 | $451 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
212 | $44 | $462 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
192 | $321 | $1,918 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
188 | $50 | $194 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
172 | $117 | $447 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
150 | $35 | $187 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
136 | $10 | $172 |
| Perflutren lipid microspheres injection Injection of perflutren lipid microspheres, measured per milliliter. |
111 | $34 | $107 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
101 | $68 | $334 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
99 | $15 | $84 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
99 | $19 | $92 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
97 | $17 | $118 |
| Cardiac catheterization | 96 | $226 | $1,246 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
90 | $8 | $49 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
86 | $23 | $220 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
85 | $6 | $56 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
66 | $82 | $480 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
63 | $13 | $151 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
58 | $12 | $144 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
56 | $45 | $244 |
| Continuous ECG monitoring with symptom tracking, up to 30 days This procedure involves continuous electrocardiogram monitoring for up to 30 days. It includes symptom monitoring to correlate heart activity with patient-reported events. |
54 | $6 | $113 |
| Continuous ECG monitoring with transmission and review Continuous electrocardiogram monitoring for up to 30 days with symptom tracking. The data is transmitted and reviewed by a healthcare professional who provides a report. |
50 | $17 | $128 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
49 | $6 | $38 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
48 | $10 | $149 |
| Heart muscle strain imaging | 46 | $27 | $133 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
46 | $28 | $117 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
45 | $155 | $859 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
42 | $82 | $768 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
28 | $137 | $387 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
19 | $177 | $875 |
| Injection, dobutamine hydrochloride, per 250 mg | 18 | $6 | $13 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
16 | $17 | $275 |
| Permanent leadless pacemaker insertion A small, self-contained pacemaker is placed directly into the heart without using wires. The procedure is guided by imaging to ensure correct positioning. |
15 | $363 | $2,167 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
15 | $37 | $331 |
| Ultrasound of heart with contrast injection An ultrasound of the heart is performed while injecting an X-ray contrast agent to improve the clarity of the images. |
15 | $25 | $113 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
14 | $16 | $134 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
13 | $79 | $292 |
| New patient office visit, complex (60-74 min) | 12 | $166 | $555 |
| Removal and replacement of dual lead permanent pacemaker This procedure involves removing an existing permanent pacemaker with two leads and replacing it with a new device. It is performed to update or repair the heart rhythm management system. |
11 | $279 | $1,682 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
11 | $8 | $49 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
24.7% high complexity
22.7% medium
52.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,440
Total received (2018-2024)
Avg $1,920/year across 7 years
Top 20% in IL for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
936
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,419 (99.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21 (0.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,705
2023
$1,581
2022
$2,591
2021
$2,747
2020
$1,451
2019
$1,721
2018
$1,644
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$200
Amgen Inc.
$181
PFIZER INC.
$173
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$169
Boston Scientific Corporation
$137
E.R. Squibb & Sons, L.L.C.
$136
Boehringer Ingelheim Pharmaceuticals, Inc.
$133
Janssen Pharmaceuticals, Inc
$115
ShockWave Medical, Inc
$106
AstraZeneca Pharmaceuticals LP
$79
Novartis Pharmaceuticals Corporation
$71
Recor Medical Inc
$44
SANOFI-AVENTIS U.S. LLC
$43
Abbott Laboratories
$34
Esperion Therapeutics, Inc.
$29
Medtronic, Inc.
$28
LANTHEUS MEDICAL IMAGING, INC.
$26
Top 3 companies account for 32.5% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$2,083
Novartis Pharmaceuticals Corporation
$1,566
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,261
E.R. Squibb & Sons, L.L.C.
$1,082
Amgen Inc.
$945
AstraZeneca Pharmaceuticals LP
$811
PFIZER INC.
$664
Boehringer Ingelheim Pharmaceuticals, Inc.
$564
Merck Sharp & Dohme LLC
$548
Boston Scientific Corporation
$537
Abbott Laboratories
$437
SANOFI-AVENTIS U.S. LLC
$416
Actelion Pharmaceuticals US, Inc.
$363
Esperion Therapeutics, Inc.
$254
Regeneron Healthcare Solutions, Inc.
$235
Amarin Pharma Inc.
$206
Medtronic, Inc.
$168
Lundbeck LLC
$144
Merck Sharp & Dohme Corporation
$141
Gilead Sciences, Inc.
$140
PREVENTRIC DIAGNOSTICS, INC.
$135
ShockWave Medical, Inc
$106
Astellas Pharma US Inc
$100
Medtronic Vascular, Inc.
$69
Philips Electronics North America Corporation
$67
BIOTRONIK INC.
$64
Kowa Pharmaceuticals America, Inc.
$62
Recor Medical Inc
$44
Alnylam Pharmaceuticals Inc.
$32
Arbor Pharmaceuticals, Inc.
$27
LANTHEUS MEDICAL IMAGING, INC.
$26
ARBOR PHARMACEUTICALS, INC.
$22
BOSTON SCIENTIFIC CORPORATION
$22
Terumo Medical Corporation
$21
Cardinal Health 200, LLC
$19
GENZYME CORPORATION
$17
Amryt Pharma Holdings Ltd
$16
Bayer HealthCare Pharmaceuticals Inc.
$12
Siemens Medical Solutions USA, Inc.
$11
Top 3 companies account for 36.5% of all-time payments
Associated products mentioned in payments ›
Asahi Fielder coronary guide wire · Azure · Azurion 7 B20 · BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM · BRILINTA · Biograph Vision · CAMZYOS · CHANTIX · CardioMEMS HF System · Cobalt · Corlanor · DEFINITY · ELIQUIS · ENTRESTO · EVKEEZA · Edarbyclor · FABRAZYME · FARXIGA · GLIDESHEATH SLENDER · HawkOne · IN.PACT Admiral · INVOKANA · JARDIANCE · JOT DX · JUXTAPID · Kerendia · LEQVIO · LEXISCAN · LINQ II · LOKELMA · LifeVest · Livalo · MULTAQ · Micra · MitraClip System · MynxGrip Vascular Closure Device · NEXIUM · NEXLETOL · NORTHERA · ONPATTRO · ONYX FRONTIER · OPSUMIT · Orsiro Mission · PARADISE RENAL DENERVATION SYSTEM · PK Papyrus · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProStyle · PressureWire FFR · Pulsar · Repatha · Reveal LINQ · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · XARELTO · Xience Alpine cornary stent system · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
6
Per 100K population
9.2
County median income
$64,962
Nearest hospital
BLESSING HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Derian is a remote & cardiac specialist, with above-average Medicare volume (top 4% in IL), with low-engagement industry engagement in the top 20% of IL peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Derian experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Derian performed 972 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Derian receive payments from pharmaceutical companies?
Yes. Dr. Derian received a total of $13,440 from 39 companies across 936 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Derian's costs compare to other cardiologists in Quincy?
Dr. Derian's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Derian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Quincy
Browse cardiologists in Quincy ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in IL
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in IL
Which IL cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology